by In2Pharma | Apr 9, 2024 | News
Belgium On 5 February 2024, the Belgian authority has published an update of the FAQ on additives. The FAQ was extended from 27 to 41 pages with the addition of 20 new questions. Source: FAQ additieven | FOD Volksgezondheid (belgium.be)
by In2Pharma | Mar 14, 2024 | News
Belgium As previously announced, since 9th of Feb 2024, Belgium and Luxembourg switched to a full EU-FMD implementation. The Belgian NCA (FAGG / AFMPS / FAMHP) now published Circular 654 for the attention of the inspectors involved in the control of the distribution...
by In2Pharma | Mar 7, 2024 | News
Belgium On February 29th, EMA published the newest version (v29) of QRD Appendix V. In this version, the contact details for reporting adverse drug reactions in Belgium has been changed, since the authority has decided to abandon the use of a postal address and go...
by In2Pharma | Mar 6, 2024 | News
Belgium The Federal Agency for the Safety of the Food Chain (FASFC) has been revamping its digital identity on its 25th anniversary with a new logo and home style. Despite the new visual identity, the core message remains the same: ensuring that all actors in the food...
by In2Pharma | Feb 26, 2024 | News
Belgium An amendment of the Belgian Royal Decree regarding the manufacture and trade of foodstuffs composed of, or containing, plants or plant preparations (RD August 31, 2021) has been published on 30 January 2024. The RD has come into force on 9 February 2024...
by In2Pharma | Feb 26, 2024 | News
Belgium Hospitals must, according to the Royal Decree of 13 September 2023, issue a tender for biological and biosimilar medicines within nine months after a first biosimilar pharmaceutical speciality, authorized in accordance with the law of March 25, 1964 on...
